KCNK2 and epilepsy: Because the TREK-1 channel deletion was shown to be deleterious for epilepsy or pain (Alloui et al. 2006; Heurteaux et al. 2004; Noel et al. 2009), we studied the effects of analog treatments on these potential side effects.